Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles
Extracellular vesicles (EV) as drug delivery nanocarriers are under intense investigation. Although clinical-grade EVs have been produced on a large-scale, low yield and high production costs of natural EVs (nEV) limit the relevant industrial translation. Recent studies show that mechanical extrusio...
Saved in:
| Main Authors: | Yi Wen, Qin Fu, Ashley Soliwoda, Sheng Zhang, Mingfeng Zheng, Wenjun Mao, Yuan Wan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Extracellular Vesicle |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773041722000026 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances of engineered extracellular vesicles-based therapeutics strategy
by: Hiroaki Komuro, et al.
Published: (2022-12-01) -
Targeting of Extracellular Vesicle-Based Therapeutics to the Brain
by: Anastasia Williams, et al.
Published: (2025-04-01) -
Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury
by: Weihang Zhou, et al.
Published: (2024-12-01) -
Cell membrane-derived nanovesicles as extracellular vesicle-mimetics in wound healing
by: Wenwen Li, et al.
Published: (2025-04-01) -
The Critical Role of Host and Bacterial Extracellular Vesicles in Endometriosis
by: Michaela Wagner, et al.
Published: (2024-11-01)